Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. Gillian Vandekerkhove

Gillian Vandekerkhove

Assistant Professor
Academic Appointment
Assistant Professor
Research Focus
Kidneys and Urinary SystemBladder Cancers
Contact Info
gvandekerkhove@prostatecentre.com
gillian-vandekerkhove/

Biography

Dr. Gillian Vandekerkhove is an assistant professor at the University of British Columbia (UBC), and senior research scientist at the Vancouver Prostate Centre. She completed her PhD and postdoctoral training at UBC with a focus on genitourinary cancer genomics. Her translational research aims to advance plasma- and urine-based liquid biopsy technologies to develop minimally invasive biomarkers and generate biological insights into urothelial cancer. Dr. Vandekerkhove leverages next-generation sequencing and computational techniques to enable precision oncology and improve outcomes for urothelial cancer patients.

News and Awards

People in profile: Gillian Vandekerkhove

Aug 24, 2018

Publications

  • Clinical cancer research : an official journal of the American Association for Cancer Research -

    Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.

    Vandekerkhove G, Todenhöfer T, Annala M, Struss WJ, Wong A, Beja K, Ritch E, Brahmbhatt S, Volik SV, Hennenlotter J, Nykter M, Chi KN, North S, Stenzl A, Collins CC, Eigl BJ, Black PC, Wyatt AW
  • Clinical cancer research : an official journal of the American Association for Cancer Research -

    ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

    Vandekerkhove G, Murtha AJ, Müller DC, Stephenson M, Rostin K, Munzur AD, Vasquez-Rios C, Nikkola J, Sipola J, Annala M, Herberts C, Fung E, Atwal J, Al-Subaie S, Parekh K, Bernales CQ, Donnellan G, Finch D, Noonan K, Ko JJ, Ozgun G, Nappi L, Kollmannsberger C, Lavoie JM, Parimi S, Todenhöfer T, Ost P, Wang G, Black PC, Maurice-Dror C, Chi KN, Eigl BJ, Wyatt AW
  • Nature communications -

    Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

    Müller DC, Murtha AJ, Bacon JVW, Stephenson M, Wells C, Vasquez-Rios C, Rostin K, Rebane L, Schönlau E, Nikkola J, Alimohamed N, Basappa NS, Finch D, Ko JJ, Lavoie JM, Nappi L, Noonan K, Ong M, Ozgun G, Parimi S, Soleimani M, Sridhar SS, Toren P, Winquist E, Bernales CQ, Koudjanian M, Atwal J, Fung E, Khan L, Eigl B, Othman D, Bismar TA, Wang G, Merza R, Papadakis AI, Spatz A, Kollmannsberger C, Maurice-Dror C, Annala M, Chi KN, Vandekerkhove G, Wyatt AW, Eigl BJ
  • Nature communications -

    Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.

    Vandekerkhove G, Lavoie JM, Annala M, Murtha AJ, Sundahl N, Walz S, Sano T, Taavitsainen S, Ritch E, Fazli L, Hurtado-Coll A, Wang G, Nykter M, Black PC, Todenhöfer T, Ost P, Gibb EA, Chi KN, Eigl BJ, Wyatt AW
  • European urology -

    Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis.

    Nikkola J, Ryyppö L, Vuorinen J, Kallio H, Selin H, Jämsä P, Åkerla J, Virtanen T, Pekkarinen T, Kaipia A, Pulkkinen J, Vandekerkhove G, Müller DC, Wyatt AW, Black PC, Nykter M, Veitonmäki T, Annala M
Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile    Create New Profile

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy